Weight Loss Drugs (BK2152) Stock Forum and Discussion

Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

1618.447
-1.825-0.11%

Close Dec 13 16:00 ET

1622.404High1599.865Low

Constituent Stocks: 7Top Rising: ALT+5.12%

ChrissyGee

4 hours ago

Covered call options have been my residual income with $Viking Therapeutics (VKTX.US)$

Understanding the Premium

Mr Long Term

Dec 12 18:17

Columns These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over.

It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed.
So what are the five worst performers on the Dow Jones Industrial Average list of blue chip stocks? Let's take a look.
1. Boeing (down 36.5%)
Boeing $Boeing (BA.US)$ has had a r...

Deep Sea

Dec 12 17:31

$Pfizer (PFE.US)$
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company's common stock to $0.43 for the first-quarter 2025 dividend, payable March 7, 2025, to holders of the Common Stock of record at the close of business on January 24, 2025. The first-quarter 2025 cash dividend will be the 345th consecutive quarterly dividend paid by Pfizer.
"Our decision to increase our quarterly dividend underscores our strong fi...

Money Thrill

Dec 12 10:06

European News. EMA, positive on reduction Kidney disease for LABEL EXTENSION

$Novo-Nordisk A/S (NVO.US)$ European Medicines Agency (EMA) has adopted a positive opinion for an update of the label of Ozempic ® (once-weekly subcutaneous semaglutide) to reflect data from the FLOW trial on renal outcomes.
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...

Moomoo Recap US

Dec 11 15:29

Columns Nasdaq Surges Past 20,000 for the First Time, Powered by Tech Giants | Wall Street Today

The $Nasdaq Composite Index (.IXIC.US)$ hit a record intraday and closing high Wednesday, crossing 20,000 points for the first time. The index was up 1.8% at 20,050 in late trading, finishing 1.77% higher. The $S&P 500 Index (.SPX.US)$ closed just below its highest close on record at 6,090.27, while the $Dow Jones Industrial Average (.DJI.US)$ fell 0.2%.
MACRO
In economic news, November’s consumer price index (C...